PMGC Holdings Inc.

ELAB Nasdaq SEC CIK 1840563
Follow PMGC Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $2.5M +784.9% vs same quarter last year
Net income −$2.4M +7.2% vs same quarter last year
EPS, diluted -
Operating cash flow −$2.3M −51.6% vs same quarter last year
Revenue by quarter
$285.9K
$304.1K
$682K
$1.3M
$2.5M
Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income5 fiscal years
  • Revenue
  • Net income
−$10M−$7.5M−$5M−$2.5M$0$2.5MFY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$590.1K−$7.7M
FY24-−$6.2M
FY23$1.7M−$4.3M
FY22$766.3K−$1.8M
FY21--
MarginsShare of revenue
  • Gross margin
  • Net margin
−1500%−1000%−500%0%500%FY21FY22FY23FY24FY25
Show the numbers
YearGross marginNet margin
FY2531.4%−1313%
FY24--
FY2366.2%−251.2%
FY2258.4%−234.9%
FY21--
Free cash flowOperating cash flow minus capital expenditure
−$8M−$6M−$4M−$2M$0FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$6.4M
FY24−$5.5M
FY23−$4.6M
FY22-
FY21-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • PMGC
  • Healthcare median
−1500%−1000%−500%0%FY21FY22FY23FY24FY25
Show the numbers
YearPMGCHealthcare median
FY25−1313%−30.6%
FY24-−47%
FY23−251.2%−58%
FY22−234.9%−80.4%
FY21-−71.8%